Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

HF 3907

1st Engrossment - 91st Legislature (2019 - 2020) Posted on 04/14/2020 02:24pm

KEY: stricken = removed, old language.
underscored = added, new language.
Line numbers 1.1 1.2 1.3 1.4 1.5
1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21

A bill for an act
relating to human services; requiring the commissioner of human services to
develop a process to identify and report 340B drugs at point of sale; requiring a
report.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1. new text begin ENCOUNTER REPORTING OF 340B ELIGIBLE DRUGS.
new text end

new text begin (a) The commissioner of human services, in consultation with federally qualified health
centers (FQHCs) and other impacted providers, shall report as provided in paragraph (b)
on the feasibility of identifying at the point of sale 340B drugs dispensed by 340B contract
pharmacies to enrollees of managed care organizations served by FQHCs in order to exclude
these claims from the Medicaid drug rebate program. In developing this report, the
commissioner shall work with managed care organizations and contracted pharmacies to
explore options for allowing FQHCs to maximize the 340B program and reimbursement
through the 340B program, while ensuring that duplicate discounts for these drugs do not
occur. The report must also detail how profits realized through the 340B program by covered
entities are currently being invested in the health care of enrollees of the managed care
organizations and how the additional revenue from the inclusion of 340B contract pharmacies
would be used by the FQHCs.
new text end

new text begin (b) The commissioner, by February 1, 2021, shall present the report described in
paragraph (a) to the chairs and ranking minority members of the legislative committees with
jurisdiction over health and human services policy and finance.
new text end